Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes: a retrospective matched-pairs analysis
Allogeneic stem cell transplantation (SCT) remains the only curative therapy for patients with high-risk myelodysplastic syndromes (MDS). Due to age, comorbidities, or lack of urgency, many receive only palliative therapies to improve quality of life. Some patients remain untreated due to a lack of...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
June 2025
|
| In: |
Annals of hematology
Year: 2025, Jahrgang: 104, Heft: 6, Pages: 3281-3288 |
| ISSN: | 1432-0584 |
| DOI: | 10.1007/s00277-025-06485-w |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00277-025-06485-w Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00277-025-06485-w 
|
| Verfasserangaben: | Katharina Anna Rauhe, Annika Kasprzak, Felicitas Schulz, Kathrin Nachtkamp, Corinna Strupp, Andrea Kündgen, Sascha Dietrich, Karin Mayer, Katharina S. Götze, Wolf-Karsten Hofmann, Aristoteles Giagounidis, Norbert Gattermann, Ulrich Germing |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1935954806 | ||
| 003 | DE-627 | ||
| 005 | 20250922091302.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250915s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00277-025-06485-w |2 doi | |
| 035 | |a (DE-627)1935954806 | ||
| 035 | |a (DE-599)KXP1935954806 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Rauhe, Katharina Anna |e VerfasserIn |0 (DE-588)1363282131 |0 (DE-627)1923095781 |4 aut | |
| 245 | 1 | 0 | |a Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes |b a retrospective matched-pairs analysis |c Katharina Anna Rauhe, Annika Kasprzak, Felicitas Schulz, Kathrin Nachtkamp, Corinna Strupp, Andrea Kündgen, Sascha Dietrich, Karin Mayer, Katharina S. Götze, Wolf-Karsten Hofmann, Aristoteles Giagounidis, Norbert Gattermann, Ulrich Germing |
| 264 | 1 | |c June 2025 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 27. Juni 2025 | ||
| 500 | |a Gesehen am 15.09.2025 | ||
| 520 | |a Allogeneic stem cell transplantation (SCT) remains the only curative therapy for patients with high-risk myelodysplastic syndromes (MDS). Due to age, comorbidities, or lack of urgency, many receive only palliative therapies to improve quality of life. Some patients remain untreated due to a lack of symptoms or low progression risk. Data on the impact of palliative therapies on overall survival (OS) and leukemia-free survival (LFS) are limited. Using the Düsseldorf MDS Registry, we compared outcomes of patients receiving red blood cell transfusions (RBCT) alone to the outcome of patients receiving RBCT combined with iron chelation therapy (ICT), erythropoietin (EPO), antithymoglobulin (ATG), or lenalidomide (LENA). Matched-pairs analysis was conducted using age, gender, and prognostic scores (Revised International Prognostic Scoring System or Chronic Myelomonocytic Leukemia-specific Prognostic Scoring System). ICT-treated patients (n = 85) had significantly improved OS (70 vs. 21 months, p < 0.001) and lower 5-year AML progression (3.5% vs. 28.2%, p < 0.001). Similar benefits were seen with EPO (n = 210; OS: 63 vs. 24 months, p < 0.001; AML: 5.7% vs. 19%, p = 0.007) and LENA (n = 30; OS: 92 vs. 57 months, p = 0.049; AML: 0% vs. 16.7%, p = 0.024). ATG (n = 11) showed no significant improvement in OS (79 vs. 64 months) or AML progression (0% vs. 18.2%). While recognizing the limitations of matched-pairs analysis versus randomized trials, our findings indicate a survival benefit from ICT, EPO, or LENA versus RBCT alone. The year of diagnosis did not independently affect OS or LFS. These results support the use of selected palliative therapies to improve long-term outcomes in MDS patients. | ||
| 650 | 4 | |a IPSS-R | |
| 650 | 4 | |a Myelodysplastic syndromes | |
| 650 | 4 | |a Non-curative therapies | |
| 650 | 4 | |a Prognosis | |
| 700 | 1 | |a Kasprzak, Annika |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schulz, Felicitas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nachtkamp, Kathrin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Strupp, Corinna |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kündgen, Andrea |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dietrich, Sascha |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mayer, Karin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Götze, Katharina S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hofmann, Wolf-Karsten |d 1967- |e VerfasserIn |0 (DE-588)114154635 |0 (DE-627)691208751 |0 (DE-576)351568336 |4 aut | |
| 700 | 1 | |a Giagounidis, Aristoteles |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gattermann, Norbert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Germing, Ulrich |d 1965- |e VerfasserIn |0 (DE-588)114105774 |0 (DE-627)607396474 |0 (DE-576)309781612 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of hematology |d Berlin : Springer, 1991 |g 104(2025), 6, Seite 3281-3288 |h Online-Ressource |w (DE-627)253389852 |w (DE-600)1458429-3 |w (DE-576)072283157 |x 1432-0584 |7 nnas |a Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes a retrospective matched-pairs analysis |
| 773 | 1 | 8 | |g volume:104 |g year:2025 |g number:6 |g pages:3281-3288 |g extent:8 |a Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes a retrospective matched-pairs analysis |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00277-025-06485-w |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s00277-025-06485-w |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250915 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 114154635 |a Hofmann, Wolf-Karsten |m 114154635:Hofmann, Wolf-Karsten |d 60000 |d 61200 |e 60000PH114154635 |e 61200PH114154635 |k 0/60000/ |k 1/60000/61200/ |p 10 | ||
| 999 | |a KXP-PPN1935954806 |e 4772328785 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"recId":"253389852","id":{"zdb":["1458429-3"],"issn":["1432-0584"],"eki":["253389852"]},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes a retrospective matched-pairs analysisAnnals of hematology","part":{"issue":"6","year":"2025","text":"104(2025), 6, Seite 3281-3288","pages":"3281-3288","volume":"104","extent":"8"},"titleAlt":[{"title":"Hematology"}],"language":["eng"],"title":[{"title":"Annals of hematology","subtitle":"organ of: Gesellschaft für Thrombose- und Hämostaseforschung, DGHO, Deutsche Gesellschaft für Hämatologie und Onkologie e.V., ÖGHO, Österreichische Gesellschaft für Hämatologie und Onkologie","title_sort":"Annals of hematology"}],"pubHistory":["62, 1 (Februrary 1991)-"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"1991","dateIssuedDisp":"1991-","publisher":"Springer","publisherPlace":"Berlin ; Heidelberg ; New York"}],"note":["Gesehen am 24.04.2025","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 80.2001: Supplement"]}],"name":{"displayForm":["Katharina Anna Rauhe, Annika Kasprzak, Felicitas Schulz, Kathrin Nachtkamp, Corinna Strupp, Andrea Kündgen, Sascha Dietrich, Karin Mayer, Katharina S. Götze, Wolf-Karsten Hofmann, Aristoteles Giagounidis, Norbert Gattermann, Ulrich Germing"]},"recId":"1935954806","id":{"eki":["1935954806"],"doi":["10.1007/s00277-025-06485-w"]},"language":["eng"],"physDesc":[{"extent":"8 S."}],"origin":[{"dateIssuedDisp":"June 2025","dateIssuedKey":"2025"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"given":"Katharina Anna","family":"Rauhe","display":"Rauhe, Katharina Anna","role":"aut"},{"display":"Kasprzak, Annika","family":"Kasprzak","given":"Annika","role":"aut"},{"given":"Felicitas","family":"Schulz","display":"Schulz, Felicitas","role":"aut"},{"role":"aut","display":"Nachtkamp, Kathrin","given":"Kathrin","family":"Nachtkamp"},{"role":"aut","given":"Corinna","family":"Strupp","display":"Strupp, Corinna"},{"family":"Kündgen","given":"Andrea","display":"Kündgen, Andrea","role":"aut"},{"role":"aut","display":"Dietrich, Sascha","family":"Dietrich","given":"Sascha"},{"role":"aut","given":"Karin","family":"Mayer","display":"Mayer, Karin"},{"role":"aut","display":"Götze, Katharina S.","family":"Götze","given":"Katharina S."},{"family":"Hofmann","given":"Wolf-Karsten","display":"Hofmann, Wolf-Karsten","role":"aut"},{"role":"aut","family":"Giagounidis","given":"Aristoteles","display":"Giagounidis, Aristoteles"},{"role":"aut","display":"Gattermann, Norbert","family":"Gattermann","given":"Norbert"},{"role":"aut","display":"Germing, Ulrich","family":"Germing","given":"Ulrich"}],"title":[{"title_sort":"Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes","subtitle":"a retrospective matched-pairs analysis","title":"Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes"}],"note":["Online veröffentlicht: 27. Juni 2025","Gesehen am 15.09.2025"]} | ||
| SRT | |a RAUHEKATHANONCURATIV2025 | ||